V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010341 | 280005792 | 1.73 | null | Palliative (P) | 2016-07-16 | 2016-08-17 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028098 | EURO-EWING |
| 280010342 | 280011729 | 1.73 | 77 | Palliative (P) | 2016-03-25 | 2016-05-20 | Cyclophosphamide oral | 02 | N | 280028101 | CYCLOPHOSPHAMIDE |
| 280010343 | 280005793 | 1.69 | 76 | Palliative (P) | 2015-09-18 | 2015-09-30 | VAI (Ifos 3g/m2) | 2 | N | 280028106 | IRINOTECAN + MDG |
| 280010344 | 280005794 | 1.72 | 75 | null | 2016-07-02 | 2016-07-09 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 280028114 | VAI |
| 280010345 | 280005796 | 1.8 | 43.7 | Palliative (P) | 2015-09-07 | 2015-09-07 | Irinotecan + Modified De Gramont | N | null | 280028121 | IRINOTECAN + TEMOZOLOMIDE |
| 280010346 | 280005798 | 1.88 | 97 | Palliative (P) | 2015-11-02 | 2015-11-08 | VAC | 02 | N | 280028123 | CAV |
| 280010347 | 280011356 | 1.62 | 51.9 | Palliative (P) | 2013-09-17 | 2013-10-05 | Etoposide + Ifosfamide (3 days) | N | N | 280028141 | ETOPOSIDE + IFOSFAMIDE |
| 280010348 | 280005802 | 1.63 | 60 | Palliative (P) | 2015-06-28 | 2015-07-13 | Oxaliplatin + Modified de Gramont | Y | N | 280028146 | OXALIPLATIN + MDG |
| 280010349 | 280005805 | 1.86 | 61.8 | null | 2015-11-30 | 2016-01-03 | VAC | N | N | 280028150 | CAV |
| 280010350 | 280005807 | 1.73 | 59.2 | Palliative (P) | 2018-01-13 | 2018-01-13 | CISPLATIN + FLUOROURACIL | N | N | 280028151 | CISPLATIN + FLUOROURACIL |
| 280010351 | 280005809 | 1.65 | 63 | Adjuvant (A) | 2018-02-16 | 2018-07-20 | Oxaliplatin + Modified de Gramont | 02 | N | 280028152 | OXALIPLATIN + MDG |
| 280010352 | 280005809 | 1.61 | 68 | Neo-adjuvant (N) | 2016-07-15 | 2016-07-15 | IRINOTECAN + TEMOZOLOMIDE | 2 | N | 280028152 | IRINOTECAN + TEMOZOLOMIDE |
| 280010353 | 280005811 | 1.79 | 85.3 | Adjuvant (A) | 2013-09-06 | 2016-07-29 | CISPLATIN + FLUOROURACIL | 02 | N | 280028168 | CISPLATIN + FLUOROURACIL |
| 280010354 | 280005811 | 1.5 | 60 | Palliative (P) | 2017-10-27 | 2017-10-27 | CARBOPLATIN + ETOPOSIDE | N | N | 280028168 | CARBOPLATIN + ETOPOSIDE |
| 280010355 | 280005813 | 1.6 | 63.9 | Palliative (P) | 2015-01-14 | 2015-01-18 | EW EuroEwing 99 : VActI | 1 | N | 280028181 | EURO-EWING |
| 280010356 | 280009047 | 1.66 | 93 | Curative (C) | 2015-02-04 | 2015-02-19 | Doxorubicin + Ifosfamide | 02 | N | 280028182 | DOXORUBICIN + IFOSFAMIDE |
| 280010357 | 280009049 | 1.6 | null | Curative (C) | 2015-02-26 | 2015-03-03 | EURO-EWING | N | N | 280028183 | EURO-EWING |
| 280010358 | 280005821 | 1.78 | null | Curative (C) | 2018-04-11 | 2018-04-17 | FLUOROURACIL + IRINOTECAN | N | N | 280028184 | VAI |
| 280010359 | 280005825 | 1.82 | 76 | Palliative (P) | 2016-12-10 | 2017-01-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 280028205 | CISPLATIN + GEMCITABINE |
| 280010360 | 280005826 | 1.68 | 72.8 | Curative (C) | null | 2015-05-19 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280028205 | CETUXIMAB + CISPLATIN + FU |
| 280010361 | 280005828 | 0 | 117.4 | Curative (C) | 2018-08-27 | 2018-08-27 | Cyclophosphamide oral | N | N | 280028214 | CYCLOPHOSPHAMIDE |
| 280010362 | 280010602 | 1.66 | 60 | Neo-adjuvant (N) | null | 2017-04-29 | Doxorubicin + Ifosfamide | null | null | 280028217 | DOXORUBICIN + IFOSFAMIDE |
| 280010363 | 280005832 | 1.63 | 0 | Palliative (P) | 2016-11-27 | 2016-12-17 | Etoposide + Ifosfamide (3 days) | 2 | N | 280028223 | ETOPOSIDE + IFOSFAMIDE |
| 280010364 | 280010603 | 1.7 | 153 | Palliative (P) | 2014-12-24 | 2015-01-30 | Carboplatin + Etoposide iv&po | N | null | 280028224 | CARBOPLATIN + ETOPOSIDE |
| 280010365 | 280005833 | 0 | 54 | Palliative (P) | 2017-07-19 | 2017-12-28 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028233 | CISPLATIN + GEMCITABINE |
| 280010366 | 280005833 | 1.66 | null | Palliative (P) | 2018-08-14 | 2018-11-07 | Irinotecan + Temozolomide | 2 | N | 280028233 | VAI |
| 280010367 | 280005834 | 1.72 | 92.4 | Palliative (P) | 2012-11-13 | 2014-06-07 | GEMCITABINE | 02 | N | 280028240 | GEMCITABINE |
| 280010368 | 280005838 | 1.73 | 78 | Palliative (P) | 2013-12-03 | 2013-12-10 | Doxorubicin + Ifosfamide | N | N | 280028255 | DOXORUBICIN + IFOSFAMIDE |
| 280010369 | 280005839 | 1.6 | 76.4 | Not known (9) | 2016-02-14 | 2016-02-22 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028256 | CETUXIMAB + CISPLATIN + FU |
| 280010370 | 280005841 | 0 | null | Palliative (P) | 2014-02-19 | 2014-02-19 | CAV | N | N | 280028259 | CAV |
| 280010371 | 280005845 | null | 104.7 | Palliative (P) | 2018-06-11 | 2018-06-14 | Cyclophosphamide oral | N | N | 280028271 | CYCLOPHOSPHAMIDE |
| 280010372 | 280005847 | 1.58 | 73.5 | Neo-adjuvant (N) | null | 2016-07-11 | CISPLATIN + FLUOROURACIL | null | null | 280028275 | CISPLATIN + FLUOROURACIL |
| 280010373 | 280005850 | null | 57.9 | null | 2013-06-25 | 2013-08-03 | Etoposide + Ifosfamide (5 days) | Y | null | 280028276 | ETOPOSIDE + IFOSFAMIDE |
| 280010374 | 280005851 | 1.69 | 81.2 | Adjuvant (A) | 2012-03-13 | 2017-04-01 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028277 | CETUXIMAB + CISPLATIN + FU |
| 280010375 | 280005853 | 1.71 | 62 | Curative (C) | 2015-12-16 | 2015-12-18 | Carboplatin + Etoposide iv&po | N | Y | 280028292 | CARBOPLATIN + ETOPOSIDE |
| 280010376 | 280005855 | 1.65 | 73 | Palliative (P) | 2016-04-24 | 2016-06-07 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | 280028299 | GEMCITABINE |
| 280010377 | 280009071 | 1.74 | 64.3 | Palliative (P) | 2014-06-08 | 2014-06-15 | Carboplatin 21day + Paclitaxel 7day | N | N | 280028300 | CARBOPLATIN + PACLITAXEL |
| 280010378 | 280005859 | 1.75 | 57 | Palliative (P) | 2013-10-13 | 2013-10-13 | Etoposide + Ifosfamide (3 days) | N | N | 280028302 | ETOPOSIDE + IFOSFAMIDE |
| 280010379 | 280005865 | 1.79 | 101.3 | Palliative (P) | 2015-01-05 | 2015-06-01 | GEMCITABINE | N | N | 280028305 | GEMCITABINE |
| 280010380 | 280009075 | 1.67 | 61.9 | Neo-adjuvant (N) | 2018-05-06 | 2018-05-28 | Etoposide + Ifosfamide (3 days) | Y | N | 280028320 | ETOPOSIDE + IFOSFAMIDE |
| 280010381 | 280005868 | 1.77 | 76.2 | Palliative (P) | 2014-08-04 | 2014-09-18 | Oxaliplatin + Modified de Gramont | null | null | 280028322 | OXALIPLATIN + MDG |
| 280010382 | 280005870 | 1.78 | null | Neo-adjuvant (N) | 2014-01-07 | 2014-01-24 | Doxorubicin + Ifosfamide | 02 | N | 280028326 | DOXORUBICIN + IFOSFAMIDE |
| 280010383 | 280005871 | 1.61 | 71.4 | Palliative (P) | 2018-02-11 | 2018-02-17 | Gemcitabine day 1&8 | N | N | 280028327 | GEMCITABINE |
| 280010384 | 280009079 | 1.85 | null | Palliative (P) | 2016-11-04 | 2016-11-05 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028330 | CETUXIMAB + CISPLATIN + FU |
| 280010385 | 280011367 | 1.9 | 95.1 | Palliative (P) | 2016-09-16 | 2016-09-30 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028334 | CETUXIMAB + CISPLATIN + FU |
| 280010386 | 280010616 | 0 | 55 | Neo-adjuvant (N) | 2016-05-14 | 2016-06-10 | GEMCITABINE | N | N | 280028335 | GEMCITABINE |
| 280010387 | 280005875 | 1.69 | null | Palliative (P) | 2017-04-06 | 2017-04-29 | GEMCITABINE | Y | N | 280028337 | GEMCITABINE |
| 280010388 | 280010617 | null | null | Palliative (P) | 2017-01-26 | 2017-01-28 | Irinotecan + Modified De Gramont | N | N | 280028345 | IRINOTECAN + TEMOZOLOMIDE |
| 280010389 | 280009083 | 1.65 | null | Palliative (P) | 2013-06-27 | 2013-06-30 | EW EuroEwing 2012 Arm A VIDE | N | null | 280028348 | EURO-EWING |
| 280010390 | 280005879 | 1.58 | 97.3 | Palliative (P) | 2017-10-13 | 2017-10-13 | EW Rel rEECur Irinotecan/Temozolomide | N | Y | 280028353 | IRINOTECAN + MDG |